IP Library › Granted Patent US 7,569,374
Granted Patent B2
US 7,569,374 · App. 12/002,392 · Granted Aug 4, 2009

HCV RNA-dependent RNA polymerase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,569,374
App. No.
12/002,392
Granted
Aug 4, 2009
Kind
B2
Abstract

The present invention features NS5B polypeptides from different clinically important HCV genotypes. The polypeptides can be used individually, or as part of a panel of RNA-dependent RNA polymerases, to evaluate the effectiveness of a compound to inhibit NS5B activity.

Claims (2)

1. A purified polypeptide comprising SEQ ID NO: 3.

2. The polypeptide of claim 1 , wherein said polypeptide consists of the amino acid sequence of SEQ ID NO:3.

Assignments (1)
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023870/0001 →